Page 320 - Traité de chimie thérapeutique 6 Médicaments antitumoraux

276 MEDICAMENTINDUISANTDES MODIFICATIONS COVALENTES DE L'ADN

HIRAISHI J. et al., Far infra-red spectra and force constants of ammine complexes of
Pt(IV), Pt(II) and Pd(II). Spectrochim. Acta, 1968, 24, 819-832.
PERUMAREDDI J.R., ADAMSON A.W., Photochemistry of complex ions. V. The photo-
chemistry of some square-planar platinum(II) complexes, J. Phys. Chem., 1968, 72,
414-420.
DHARA S.C. lndian J. Chem., 1970, 8, 193-194.
KIDANI Y. et al., Antitumor activity of 1,2-diaminocyclohexane-platinum complexes
against sarcoma-180 ascites form, J. Med. Chem., 1978, 21, 1315-1318.
SUNDQUIST W.I., AHMED K.J., HOLLIS L.S., LIPPARD S.J., Solvolysis reactions of cis-
and trans-diammine dichloroplatinum(II) in dimethyl sulfoxide. Structural characteri-
zation and DNA binding of trans-bis(ammine) chloro(DMSO)platinum, lnorg. Chem.,
1987, 26, 1524-1528.
ALLSOPP M.A. et al., The degradation of carboplatin in aqueous solutions containing
chloride or other selected nucleophiles, /nt. J. Pharm., 1991, 69, 197-210.
PASINI A., CALDIROLA C., SPI NELU S., VALSECCHI M., Comments on different syn-
thetic methods for the preparation of diammine and bis(amine) organodicarboxylato-
platinum(ll) complexes, Synth. React. Inorg. Met.-Org. Chem., 1993, 23, 1021-1060.
FREY U. et al., Ring-Opening Reactions of the Anticancer Drug Carboplatin : NMR Cha·
racterization of cis-[Pt(NH,),(CBDCA-O)-(5'-GMP-NT)] in Solution, Inorg. Chem.,
1993, 32, 1333-1340.
MURDOCH P. del S. et al., Cis-Trans Isomerization of [Pt(L-methionine),] : Metabolite of
the Anticancer Drug Cisplatin, Inorg. Chem., 1993, 32, 2249-2255.
GIANDOMENICO C.M. et a/., Carboxylation of kinetically inert platinum(IV) hydroxy com-
plexes. An entrée into orally active platinum(IV) antitumor agents, Inorg. Chem., 1995,
34, 1015-1021.
TORRES F., et al., Stability of carboplatin in 5 % glucose solution exposed to light, /nt.
J. Pharm., 1996, 129, 275-277.
CARBALLAR R.J. et al., Stability study of carboplatin in aqueous solution and under
illumination by high performance liquid chromatography, Biomed. Chromatogr., 1997,
11,119-120.
NAGAO N. et al., Platinum(II) complexes with diglycine : X-ray crystal structure, 1 SN NMR
spectra, and growth-inhibitory activity against mouse Meth A solid tumor in vivo,
Inorg. Chem. 1997, 36, 4195-4201.
NAKAMOTO K., Applications in coordination chemistry, in: lnfrared and Raman Spectra
of lnorganic and Coordination Compounds, ed, J. Wiley & Sons, Inc. 1997, 1-112.
ONISHI H., HPLC fordetermination of impurities in anticancer platinum compounds, Jpn.
Kokai Tokkyo Koho JP 09257781 A2, 3 Oct 1997 Heisei. Chem. Abstr., 1997, 127,
351345.
TANIUCHI J.I., NAKANISHI C., OHNISHI Y., Process of preparing platinum cyclohexa-
nediamine oxalate complexes of high purity, Eur. Pat. Appl. EP 801070 A2, 15 Oct
1997 ; Chem. Abstr., 1997, 127, 302489.
CHEN Y. et al., Stereospecific and kinetic contrai over the hydrolysis of a sterically hin-
dered platinum picoline anticancer complex, Chem. Eur. 4., 1998, 4, 672-676.
HINDMARSH K. et al., The redox kinetics of platlnum(ll))/(IV) complexes, /norg. Chim.
Acta, 1998, 278, 32-42.